HomeMedical SpecialtiesAddictions and DrugsScientist receives funding for smoking vaccine

Scientist receives funding for smoking vaccine

Published on

By Maggie Frampton

Ontario has higher rates of smoking than the provincial and national average. Over 45,000 Canadians die from smoking related diseases each year. There is an undeniable link between smoking and cancer, heart and lung diseases.

Dr. Hoang-Thanh Le, Scientist at Health Sciences North Research Institute, the research institute for Health Sciences North in Sudbury, Ontario, has received funding from the Canadian Institutes of Health Research (CIHR) for the development of an intranasal vaccine using a novel adjuvant delivery system.

The vaccine is showing promising preliminary results. “Only a small group of people see long term success with the current smoking cessation options.  The nicotine vaccine would be a likely option for treatment that suppresses the addiction”, says Dr. Le.

Dr. Le has been developing the vaccine since 2011 when he first received support from Grand Challenges Canada and Northern Cancer Foundation. The project involves collaborations with partners at the Centre for Addictions and Mental Health in Toronto, Ontario; Health Sciences North Research Institute in Sudbury, Ontario; Pasteur Institute in Ho Chi Minh City, Vietnam; and Indian Institute of Science Education and Research in Kolkata, India.

Dr. Le and his team propose to develop a new vaccination strategy targeting the lungs, which offers an effective treatment that can sequester nicotine in the airways and limit its entry into the brain. Preliminary results show that levels of nicotine in the brains of vaccinated mice were four times lower than those not vaccinated. The new proposed strategy, which is easily administered through the nose, skin or under the tongue, could be able to aid people who smoke to successfully quit and also to prevent smoking.

“We are very excited for Dr. Le and his research team for receiving funding from CIHR. The development of this research will help many patients in Northern Ontario and beyond”, says Dr. McElhaney, Vice President of Research & Scientific Director at Health Sciences North Research Institute.

Dr. Le anticipates starting human clinical trials once all safety and efficacy testing has been concluded in animals. This vaccine would benefit patients by reducing the risk of cancers, heart disease and stroke.

The vaccine will not require any needles making it more cost effective than traditional vaccines. This safe and effective approach to vaccination could be further developed for other addictions such as cocaine, heroin, and methamphetamine.

Maggie Frampton is a Communications Specialist at Health Sciences North.

Latest articles

Alcohol-related deaths up 18% during pandemic

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use,...

The Canadian Consensus Statement on the management of venous leg ulcers

This Consensus Statement was developed with the objective of creating a concise document that...

A pathway to independence for patients with rare disease

Nearly 20 years ago, Audrey Gouskos came through the St. Michael’s Hospital Emergency Department...

Robotic-assisted rehabilitation now available in Fraser Health

Stroke patient Leanne Mork is learning to walk again with the assistance of a...

More like this

Free toolkit to support mental health in the workplace

The Canadian Centre for Occupational Health and Safety (CCOHS) has released a free Workplace Mental...

Move more, age well: prescribing physical activity for older adults as a recipe for healthy aging

Can physical activity extend the lifespans of older adults? A review article published in CMAJ (Canadian...

Antipsychotic use has been rising in long-term care homes, but we can do something about it – we’ve done it before

As health care providers working in long-term care (LTC), we’ve seen firsthand how antipsychotic...

Sinai Health team sheds light on COVID-19 variant dynamics in Toronto

The worst days of the pandemic may be behind us, but research into the...

Safe medication use of blood thinning medications

blood clot is an accumulation of blood that has thickened and clumped together. The...

Canadian first: Sunnybrook achieves second level of age-friendly health system designation

Sunnybrook Health Sciences Centre is proud to announce a first-in-Canada recognition, as we received...